Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination

  • Sánchez-Simarro, Ángela
  • Fernández-Soto, Daniel
  • Grau, Brayan
  • Albert, Eliseo
  • Giménez, Estela
  • Avilés-Alía, Ana Isabel
  • Gozalbo-Rovira, Roberto
  • Rusu, Luciana
  • Olea, Beatriz
  • Geller, Ron
  • Reyburn, H. T.
  • Navarro, David
The immune effector mechanisms involved in protecting against severe COVID-19 infection in elderly nursing home residents following vaccination or natural infection are not well understood. Here, we measured SARS-CoV-2 Spike (S)-directed functional antibody responses, including neutralizing antibodies (NtAb) and antibody Fc-mediated NK cell activity (degranulation and IFNγ production), against the Wuhan-Hu-1, BA.4/5 (for NtAb), and Omicron XBB.1.5 variants in elderly nursing home residents (n = 39; median age, 91 years) before and following a third (pre- and post-3D) and a fourth (pre- and post-4D) mRNA COVID-19 vaccine dose. Both 3D and 4D boosted NtAb levels against both (sub)variants. Likewise, 3D and 4D increased the ability of sera to trigger both LAMP1- and IFNγ-producing NK cells, in particular against XBB.1.5. In contrast to NtAb titres, the frequencies of LAMP1- and IFNγ-producing NK cells activated by antibodies binding to Wuhan-Hu-1 and Omicron XBB.1.5 S were comparable at all testing times. Stronger functional antibody responses were observed in vaccine-experienced participants compared to vaccine-naïve at some testing times. These findings can contribute to identifying a reliable correlate of protection in elderly nursing home residents against severe COVID-19 and inform future vaccine strategies in this population group., Ángela Sánchez-Simarro has a contract funded by the Carlos III Health Institute (PFIS Contract; FI22/00338). Eliseo Albert holds a contract funded by the Carlos III Health Institute (co-financed by the European Regional Development Fund, ERDF/FEDER): Juan Rodés Contract; JR20/00011. Brayan Grau is supported by a Juan de la Cierva postdoctoral fellowship (FJC2021-046453-I). This study was supported by the Instituto de Salud Carlos III, Madrid, Spain (FIS, PI21/00563) granted to David Navarro, by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC-COVID19-028), and a grant from the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU): PID2020-115506RB-I00 (HTR)]. The CNB also acknowledges financial support from the Spanish State Research Agency, AEI/https://doi.org/10.13039/501100011033, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (SEV-2013-0347, SEV-2017-0712). D. Fernández Soto is a recipient of a fellowship (PRE2018-083200) from the Spanish Ministry of Science and Innovation and is a graduate student in the Molecular Biosciences doctoral program of the Autonomous University of Madrid. This research work was also funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through the CSIC's Global Health Platform (PTI Salud Global) to Ron Geller and Hugh Reyburn., Peer reviewed